A founder’s novel idea to prove his wearable works
In February 2020, Apollo Neuro, a startup that had raised $7 million in seed funding and had just launched, was set to do three sleep studies that would test whether its vibrational device could improve a person’s ability to sleep. At that point, they had 4,500 active users of their first generation wearable.
When the pandemic hit in March, his studies, which were to be conducted inside of sleep labs, were knocked offline. But Dr. Dave Rabin pivoted. He knew that a good chunk of Apollo Neuro users also had an Oura Ring, a wearable that tracks sleep. Oura’s sleep tracking platform was not quite as good as polysomnography, the gold standard for sleep research, but it was pretty close. He reached out to the company and asked if he could use their platform to see the impact of the Apollo Neuro on users’ sleep. Oura said yes.
Apollo Neuro says it’s charting towards profitability in the next year. And though there is seasonality and other hiccups that can befall direct-to-consumer products, they’ve focused on delivering a defined benefit to their customers. It appears to be working.
So what? Apollo Neuro’s novel idea ultimately led to a strong connection with another wearable company that could deliver the proof points it needed to show the value of its wearable. And it saved massive amounts of money. That is a major deal for companies that are under immense pressure to keep burn rates low. Outside of buzzy AI niches, the market has shifted in the years since the pandemic to make it far more challenging to raise capital.
“The study cost us so little money to do. It cost us probably like $50,000,” Rabin told me. “If we were to do this in a clinical framework, it would cost millions of dollars.”
The Sleep Study
The result is a three-year study, conducted in collaborations with researchers at the University of Pittsburgh Medical Center and Emory University, that shows the Apollo Neuro was able to increase sleep time, particularly for those who are chronic short sleepers. People who regularly sleep less than 6 hours per night were able to gain an average of 45 minutes of sleep on average after using the Apollo Neuro after cumulatively using the device for four hours. Put another way, users saw significant sleep improvements after four hour-long sessions with Apollo Neuro’s device.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,
What will AI do for employer healthcare and benefits?
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.
Hospitals as the new go-to-market, lessons from the trenches
Watch the Full Webinar Health systems are entering a new frontier, one where innovation isn’t optional, and meaningful change requires creativity,
Breaking Point: How Healthcare Costs Are Reshaping Employer Strategies
In this Second Opinion webinar, we’ll bring together economists, benefits leaders, and innovators to unpack what’s driving today’s cost crisis, why traditional containment strategies are falling short, and which approaches are beginning to break through.